Adjunctive Zonisamide + Replacement with Zonisamide
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Partial Seizures
Conditions
Partial Seizures
Trial Timeline
Sep 1, 2009 → Jul 1, 2012
NCT ID
NCT01630057About Adjunctive Zonisamide + Replacement with Zonisamide
Adjunctive Zonisamide + Replacement with Zonisamide is a approved stage product being developed by Eisai for Partial Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT01630057. Target conditions include Partial Seizures.
What happened to similar drugs?
17 of 20 similar drugs in Partial Seizures were approved
Approved (17) Terminated (5) Active (3)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01630057 | Approved | Completed |
Competing Products
20 competing products in Partial Seizures
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| E2007 | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Pre-clinical | 26 |
| perampanel + perampanel | Eisai | Phase 1 | 29 |
| perampanel + perampanel + perampanel + Placebo | Eisai | Phase 3 | 40 |
| Perampanel + Placebo | Eisai | Approved | 35 |
| Perampanel and Microgynon-30 + Perampanel and Microgynon-30 | Eisai | Phase 1 | 29 |
| perampanel | Eisai | Phase 2 | 35 |
| Perampanel | Eisai | Pre-clinical | 26 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| zonisamide | Eisai | Pre-clinical | 26 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 40 |
| Perampanel + Placebo | Eisai | Phase 3 | 40 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 40 |
| Fycompa | Eisai | Pre-clinical | 26 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| Fycompa | Eisai | Pre-clinical | 26 |
| Rufinamide | Eisai | Phase 3 | 32 |
| Zonisamide | Eisai | Phase 3 | 40 |
| Eslicarbazepine Acetate tablets | Eisai | Pre-clinical | 26 |
| Perampanel | Eisai | Pre-clinical | 26 |